Company · CIK 0001808805 · SIC 3826 — Laboratory Analytical Instruments · Nasdaq
Nautilus Biotechnology, Inc. · NAUT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 SForm 4 → | Jun 4, 4:53 pm EDT | AH Equity Partners Bio II, L.L.C. +510% Owner | 5,000,000 | $2.35 | $11,750,000 | 971,885 | −83.7% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 AForm 4 → | Jun 22, 4:14 pm EDT | Matthew L. PosardDirector | 45,000 | — | — | 45,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 4:14 pm EDT | Farzad NazemDirector | 45,000 | — | — | 45,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 4:13 pm EDT | Karen AkinsanyaDirector | 45,000 | — | — | 45,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 4:13 pm EDT | Matthew S McIlwainDirector | 45,000 | — | — | 45,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 4:13 pm EDT | Melissa B, EpperlyDirector | 45,000 | — | — | 45,000 | — |